BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1705463)

  • 1. Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid.
    Botez MI; Young SN
    Brain; 1991 Feb; 114 ( Pt 1A)():333-48. PubMed ID: 1705463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
    Botez MI; Young SN
    Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of biogenic amine levels in the Rett syndrome.
    Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
    N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid and blood thiamine concentrations in phenytoin-treated epileptics.
    Botez MI; Joyal C; Maag U; Bachevalier J
    Can J Neurol Sci; 1982 Feb; 9(1):37-9. PubMed ID: 7093823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate and monoamine metabolism in epilepsy.
    Reynolds EH; Chadwick D; Jenner P; Chanarin I
    J Neurol Sci; 1975 Dec; 26(4):605-15. PubMed ID: 1206436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
    Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
    Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine deficiency and cerebrospinal fluid 5-hydroxyindoleacetic acid: a preliminary study.
    Botez MI; Young SN; Bachevalier J; Gauthier S
    J Neurol Neurosurg Psychiatry; 1982 Aug; 45(8):731-3. PubMed ID: 6182272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary abnormalities of neurotransmitters in infants with neurological disorders.
    García-Cazorla A; Serrano M; Pérez-Dueñas B; González V; Ormazábal A; Pineda M; Fernández-Alvarez E; Campistol JM; Artuch RM
    Dev Med Child Neurol; 2007 Oct; 49(10):740-4. PubMed ID: 17880642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 18. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.